Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2019 Filed Dec 16, 2019 22:40 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionCommon Stock | 2,017 | $62.62 | $126,304.54 |
DisclosureSEC source: 0001225208-19-015859 · doc4.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,736.2521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 23:05 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 349.415 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015729 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,425.0333 Underlying: Common Stock · 349.415 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 11, 2019 Filed Feb 13, 2020 21:10 UTC |
PEREZ WILLIAM DDirector
|
GiftCommon Stock | 2,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002167 · doc4.xml · nonDerivative · entry 1 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,530 Read SEC document |
| September 10, 2019 Filed Sep 11, 2019 20:11 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 382.388 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-012323 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,075.6183 Underlying: Common Stock · 382.388 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| June 11, 2019 Filed Jun 11, 2019 21:01 UTC |
HEWSON MARILLYN ADirector
|
PurchaseCommon Stock | 3,000 | $139.68 | $419,040.00 |
DisclosureSEC source: 0001225208-19-009128 · doc4.xml · nonDerivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 21:10 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 349.616 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-009184 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,693.2303 Underlying: Common Stock · 349.616 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| May 07, 2019 Filed Feb 12, 2020 23:47 UTC |
Ullmann Michael HExec VP, General Counsel
|
GiftCommon Stock | 353 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002102 · doc4.xml · nonDerivative · entry 2 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,370.882 F1 · shares: Gift Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 16:46 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 340.632 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-005181 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,343.6143 Underlying: Common Stock · 340.632 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 28, 2019 Filed Feb 12, 2020 23:47 UTC |
Ullmann Michael HExec VP, General Counsel
|
GiftCommon Stock | 736 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002102 · doc4.xml · nonDerivative · entry 1 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,723.882 F1 · shares: Gift Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:14 UTC |
Beckerle Mary CDirector
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002391 · doc4.xml · derivative · entry 1 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,222.439 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:55 UTC |
DAVIS D SCOTTDirector
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002417 · doc4.xml · derivative · entry 1 DAVIS D SCOTT · CIK 0001227733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,921.888 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:55 UTC |
PRINCE CHARLESDirector
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002418 · doc4.xml · derivative · entry 1 PRINCE CHARLES · CIK 0001225179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,576.898 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:55 UTC |
PEREZ WILLIAM DDirector
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002419 · doc4.xml · derivative · entry 1 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,254.418 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:55 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002420 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,002.9823 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:55 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002421 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,360.73 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:55 UTC |
MULCAHY ANNE MDirector
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002422 · doc4.xml · derivative · entry 1 MULCAHY ANNE M · CIK 0001201725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,007.189 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:55 UTC |
McClellan Mark B.Director
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002423 · doc4.xml · derivative · entry 1 McClellan Mark B. · CIK 0001567006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,884.291 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:55 UTC |
Doudna Jennifer ADirector
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002424 · doc4.xml · derivative · entry 1 Doudna Jennifer A · CIK 0001739090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,402 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 19:55 UTC |
Davis IanDirector
|
GrantDeferred Share Units · Derivative | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002425 · doc4.xml · derivative · entry 1 Davis Ian · CIK 0001494009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,007.189 Underlying: Common Stock · 1,402 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Duato JoaquinVice Chair, Exec Committee
|
GrantRestricted Share Units · Derivative | 5,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 10 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,424 Underlying: Common Stock · 5,424 shares Expires not disclosed F8 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F8 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionPerformance Share Units · Derivative | 22,624 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 9 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,624 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Duato JoaquinVice Chair, Exec Committee
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 110,868 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 8 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,868 Underlying: Common Stock · 110,868 shares Expires 2029-02-11 F7 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Tax withholdingCommon Stock | 11,435 | $131.94 | $1,508,733.90 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 5 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,705 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Duato JoaquinVice Chair, Exec Committee
|
GrantCommon Stock | 3,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 4 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,140 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionCommon Stock | 22,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GrantRestricted Share Units · Derivative | 11,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002348 · doc4.xml · derivative · entry 13 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,129 Underlying: Common Stock · 11,129 shares Expires not disclosed F10 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F10 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Gorsky AlexDirector · Chairman, CEO
|
Exercise / conversionPerformance Share Units · Derivative | 73,947 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002348 · doc4.xml · derivative · entry 12 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 73,947 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F4 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 227,464 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002348 · doc4.xml · derivative · entry 11 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,464 Underlying: Common Stock · 227,464 shares Expires 2029-02-11 F9 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Gorsky AlexDirector · Chairman, CEO
|
Tax withholdingCommon Stock | 37,374 | $131.94 | $4,931,125.56 |
DisclosureSEC source: 0001225208-19-002348 · doc4.xml · nonDerivative · entry 7 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,456 F6 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GrantCommon Stock | 12,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002348 · doc4.xml · nonDerivative · entry 6 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,830 F5 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Gorsky AlexDirector · Chairman, CEO
|
Exercise / conversionCommon Stock | 73,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002348 · doc4.xml · nonDerivative · entry 5 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantRestricted Share Units · Derivative | 2,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002349 · doc4.xml · derivative · entry 11 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,885 Underlying: Common Stock · 2,885 shares Expires not disclosed F10 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F10 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Exercise / conversionPerformance Share Units · Derivative | 7,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002349 · doc4.xml · derivative · entry 10 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,541 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 58,972 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002349 · doc4.xml · derivative · entry 9 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,972 Underlying: Common Stock · 58,972 shares Expires 2029-02-11 F9 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Tax withholdingCommon Stock | 3,578 | $131.94 | $472,081.32 |
DisclosureSEC source: 0001225208-19-002349 · doc4.xml · nonDerivative · entry 5 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,468.4243 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantCommon Stock | 1,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002349 · doc4.xml · nonDerivative · entry 4 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,046.4243 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Exercise / conversionCommon Stock | 7,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002349 · doc4.xml · nonDerivative · entry 3 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,809.4243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
Exercise / conversionPerformance Share Units · Derivative | 16,968 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · derivative · entry 7 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
Tax withholdingCommon Stock | 11,577 | $131.94 | $1,527,469.38 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 5 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,344 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
GrantCommon Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 4 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,921 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
Exercise / conversionCommon Stock | 16,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 3 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
GrantRestricted Share Units · Derivative | 1,517 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002351 · doc4.xml · derivative · entry 11 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,517 Underlying: Common Stock · 1,517 shares Expires not disclosed F9 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F9 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionPerformance Share Units · Derivative | 7,275 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002351 · doc4.xml · derivative · entry 10 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 31,003 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002351 · doc4.xml · derivative · entry 9 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,003 Underlying: Common Stock · 31,003 shares Expires 2029-02-11 F8 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Tax withholdingCommon Stock | 3,497 | $131.94 | $461,394.18 |
DisclosureSEC source: 0001225208-19-002351 · doc4.xml · nonDerivative · entry 5 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,383 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
GrantCommon Stock | 1,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002351 · doc4.xml · nonDerivative · entry 4 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,880 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionCommon Stock | 7,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002351 · doc4.xml · nonDerivative · entry 3 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
GrantRestricted Share Units · Derivative | 5,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 9 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,606 Underlying: Common Stock · 5,606 shares Expires not disclosed F7 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F7 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
Exercise / conversionPerformance Share Units · Derivative | 31,428 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 8 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 114,575 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 7 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,575 Underlying: Common Stock · 114,575 shares Expires 2029-02-11 F6 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.